Cancer Control

该期刊要求在投稿过程中列出每位作者的具体贡献，并在致谢部分之后加入“作者贡献”标题，投稿时填写的信息将在校对阶段显示于该标题之下。 模型中文摘要

You will be asked to list the contribution of each author as part of the submission process. Please include the Author Contributions heading within your submission after the Acknowledgements section. The information you give on submission will then show under the Author Contributions heading later at the proofing stage.

该期刊致力于促进研究的开放、透明和可重复性，鼓励作者在符合伦理和法律要求的前提下，将研究数据存入相关公共数据仓库、提供链接数据的数据可用性声明（如无法共享则说明原因），并在研究中引用这些数据。 模型中文摘要

The Journal is committed to facilitating openness, transparency and reproducibility of research, and has the following research data sharing policy. For more information, including FAQs please visit the Sage Research Data policy pages. Subject to appropriate ethical and legal considerations, authors are encouraged to: Share your research data in a relevant public data repository Include a data ava…

该期刊要求作者在指定标题下提供伦理批准声明（即使方法部分已包含），若无需伦理批准也须明确说明；涉及人类参与者、人类数据或人体组织的研究必须声明相关伦理委员会或机构审查委员会批准或豁免批准，并提供委员会全称、所属机构及批准编号。 模型中文摘要

Please include your ethics approval statements under this heading, even if you have already included ethics approval information in your methods section. If ethical approval was not required, you need to explicitly state this. All papers reporting studies involving human participants, human data or human tissue must state that the relevant Ethics Committee or Institutional Review Board approved th…

Cancer Control 是开放获取、同行评审期刊，录用文章在出版后立即免费在线发布，采用知识共享许可并永久在线保存；同行评审后录用时需一次性支付文章处理费（APC）3200 美元，由资助者、机构或作者承担，投稿不收费，部分文章类型可享折扣或免收。 模型中文摘要

Cancer Control is an open access, peer-reviewed journal. All accepted articles are made freely available online immediately upon publication, are published under a Creative Commons license, and hosted online in perpetuity. If, after peer review, your manuscript is accepted for publication, a one-time article processing charge (APC) is payable to cover the cost of publishing, paid by the funder, in…

该期刊实行双匿名同行评审，稿件先经初步评估，不符合指南要求的稿件将被退回修改，超出范围或不合适的稿件可能未经同行评审即被直接拒稿。 模型中文摘要

The following summary describes the peer review process for this journal: Identity transparency:Double-anonymized Reviewer interacts with: Executive Editor, Deputy Editor, Managing Editors, Section Editors Review information published: Review reports (author opt in) Review reports (reviewer opt in) Author/editor communication Reviewer identities (reviewer opt in) Your manuscript will undergo an in…

该期刊和 Sage 高度重视版权侵犯、抄袭及其他违反出版最佳实践的行为，并建议作者阅读 Sage 完整的抄袭政策及其可能采取的措施。 模型中文摘要

The journal and Sage take issues of copyright infringement, plagiarism or other breaches of best practice in publication very seriously. Please read Sage's complete policy on plagiarism and the actions we may take.

该期刊接受已在预印本服务器上发布的稿件，投稿时需在指定字段填写预印本 DOI，并建议在投稿时告知编辑部；同行评审期间不应在预印本服务器上发布更新版本。 模型中文摘要

The journal will consider submissions of manuscripts that have been posted on preprint servers. Please enter the preprint DOI in the designated field when submitting your manuscript. We advise that you inform the Journal Editorial office about your posted preprint at submission. Note that you should not post an updated version of your manuscript on a preprint server while it is being peer reviewed…

该期刊遵循 ICMJE 要求，临床试验须在首个受试者入组时或之前在经 WHO 批准的公共试验注册机构注册，作为发表考虑的条件，并须在摘要末尾注明注册机构名称、网址及注册号。 模型中文摘要

The journal conforms to the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first participant enrollment as a condition of consideration for publication. The trial registry name and URL, and registration number must be included at the end of the abstract.